Annual Operating Expenses
$329.98 M
+$68.90 M+26.39%
December 31, 2024
Summary
- As of March 13, 2025, ABCL annual total operating expenses is $329.98 million, with the most recent change of +$68.90 million (+26.39%) on December 31, 2024.
- During the last 3 years, ABCL annual operating expenses has risen by +$222.19 million (+206.14%).
- ABCL annual operating expenses is now at all-time high.
Performance
ABCL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$74.26 M
-$22.42 M-23.19%
December 31, 2024
Summary
- As of March 13, 2025, ABCL quarterly total operating expenses is $74.26 million, with the most recent change of -$22.42 million (-23.19%) on December 31, 2024.
- Over the past year, ABCL quarterly operating expenses has dropped by -$22.42 million (-23.19%).
- ABCL quarterly operating expenses is now -23.81% below its all-time high of $97.47 million, reached on June 30, 2024.
Performance
ABCL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ABCL Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.4% | -23.2% |
| 3 y3 years | +206.1% | -23.2% |
| 5 y5 years | +2264.6% | -23.2% |
ABCL Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +206.1% | -23.8% | +142.9% |
| 5 y | 5-year | at high | +2264.6% | -23.8% | +1654.8% |
| alltime | all time | at high | +4029.9% | -23.8% | +1654.8% |
AbCellera Biologics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $329.98 M(+26.4%) | $74.26 M(-23.2%) |
| Sep 2024 | - | $96.68 M(-0.8%) |
| Jun 2024 | - | $97.47 M(+58.3%) |
| Mar 2024 | - | $61.57 M(-14.3%) |
| Dec 2023 | $261.08 M(+36.0%) | $71.86 M(+22.5%) |
| Sep 2023 | - | $58.66 M(+3.2%) |
| Jun 2023 | - | $56.87 M(-22.8%) |
| Mar 2023 | - | $73.69 M(+31.4%) |
| Dec 2022 | $191.92 M | $56.09 M(+20.7%) |
| Sep 2022 | - | $46.46 M(-2.3%) |
| Jun 2022 | - | $47.57 M(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $41.80 M(+36.7%) |
| Dec 2021 | $107.79 M(+158.7%) | $30.57 M(+4.6%) |
| Sep 2021 | - | $29.22 M(+10.6%) |
| Jun 2021 | - | $26.42 M(+22.8%) |
| Mar 2021 | - | $21.51 M(-1.7%) |
| Dec 2020 | $41.66 M(+198.5%) | $21.89 M(+123.5%) |
| Sep 2020 | - | $9.79 M(+131.4%) |
| Jun 2020 | - | $4.23 M(-26.4%) |
| Mar 2020 | - | $5.75 M(+23.8%) |
| Dec 2019 | $13.96 M(+74.7%) | $4.64 M |
| Dec 2018 | $7.99 M | - |
FAQ
- What is AbCellera Biologics annual total operating expenses?
- What is the all time high annual operating expenses for AbCellera Biologics?
- What is AbCellera Biologics annual operating expenses year-on-year change?
- What is AbCellera Biologics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AbCellera Biologics?
- What is AbCellera Biologics quarterly operating expenses year-on-year change?
What is AbCellera Biologics annual total operating expenses?
The current annual operating expenses of ABCL is $329.98 M
What is the all time high annual operating expenses for AbCellera Biologics?
AbCellera Biologics all-time high annual total operating expenses is $329.98 M
What is AbCellera Biologics annual operating expenses year-on-year change?
Over the past year, ABCL annual total operating expenses has changed by +$68.90 M (+26.39%)
What is AbCellera Biologics quarterly total operating expenses?
The current quarterly operating expenses of ABCL is $74.26 M
What is the all time high quarterly operating expenses for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total operating expenses is $97.47 M
What is AbCellera Biologics quarterly operating expenses year-on-year change?
Over the past year, ABCL quarterly total operating expenses has changed by -$22.42 M (-23.19%)